Sofinnova Investments, Inc.
- SEC CIK
- 0001631134
- 最新申報
- 2026/8/14
2021 年第 2 季持倉
持倉截至 2021/6/30，2021/8/16 申報。只含多頭部位，變化是跟 2021 年第 1 季比股數。
- 持股檔數
- 61
- 較 2021 年第 1 季 +1
- 總值
- $16.5 億
- 較 2021 年第 1 季 +$6,026 萬 (+3.8%)
| 證券 | 類別 | 股數 | 市值 | 佔組合 % | 股數變化 | 動作 | 紀錄 |
|---|---|---|---|---|---|---|---|
| NTRANatera, Inc. | COM | 3,100,560 | $3.52 億 | 21.4% | 00.0% | 不變 | 歷史 |
| KRTXKaruna Therapeutics, Inc. | COM | 1,952,441 | $2.23 億 | 13.5% | 00.0% | 不變 | 歷史 |
| JBIOJade Biosciences, Inc. | COM | 3,758,686 | $8,581 萬 | 5.2% | +3,758,686 | 新進 | 歷史 |
| YMABY-mAbs Therapeutics, Inc. | COM | 2,194,278 | $7,417 萬 | 4.5% | 00.0% | 不變 | 歷史 |
| ASNDAscendis Pharma A/S | SPONSORED ADR | 521,923 | $6,866 萬 | 4.2% | 00.0% | 不變 | 歷史 |
| AZNAstraZeneca PLC | SPONSORED ADR | 959,632 | $5,748 萬 | 3.5% | −76,100−7.3% | 減碼 | 歷史 |
| BOLTBolt Biotherapeutics, Inc. | COM | 2,754,437 | $4,258 萬 | 2.6% | 00.0% | 不變 | 歷史 |
| UTHRUnited Therapeutics Corp | COM | 216,085 | $3,877 萬 | 2.4% | +1,031+0.5% | 加碼 | 歷史 |
| VERAVera Therapeutics, Inc. | CL A | 2,914,776 | $3,865 萬 | 2.3% | +2,914,776 | 新進 | 歷史 |
| BIIBBiogen Inc. | COM | 110,600 | $3,830 萬 | 2.3% | +110,600 | 新進 | 歷史 |
| INZYInozyme Pharma, Inc. | COM | 2,028,308 | $3,456 萬 | 2.1% | 00.0% | 不變 | 歷史 |
| GRTXGalera Therapeutics, Inc. | COM | 3,083,712 | $3,031 萬 | 1.8% | 00.0% | 不變 | 歷史 |
| XLRNAcceleron Pharma Inc | COM | 233,638 | $2,932 萬 | 1.8% | +55,100+30.9% | 加碼 | 歷史 |
| ALGNAlign Technology Inc | COM | 47,093 | $2,877 萬 | 1.7% | +1,593+3.5% | 加碼 | 歷史 |
| PTCTPTC Therapeutics, Inc. | COM | 581,940 | $2,460 萬 | 1.5% | +115,100+24.7% | 加碼 | 歷史 |
| INSMINSMED Inc | COM PAR $.01 | 844,169 | $2,403 萬 | 1.5% | +225,219+36.4% | 加碼 | 歷史 |
| SRPTSarepta Therapeutics, Inc. | COM | 298,500 | $2,321 萬 | 1.4% | +298,500 | 新進 | 歷史 |
| HRTXHeron Therapeutics, Inc. | COM | 1,467,675 | $2,278 萬 | 1.4% | +1,467,675 | 新進 | 歷史 |
| CMPICheckmate Pharmaceuticals, Inc. | COM | 3,606,707 | $2,150 萬 | 1.3% | 00.0% | 不變 | 歷史 |
| NXTCNextCure, Inc. | COM | 2,671,856 | $2,146 萬 | 1.3% | 00.0% | 不變 | 歷史 |
| PTGXProtagonist Therapeutics, Inc | COM | 449,082 | $2,016 萬 | 1.2% | −205,818−31.4% | 減碼 | 歷史 |
| NBIXNeurocrine Biosciences Inc | Stock | 203,200 | $1,978 萬 | 1.2% | +203,200 | 新進 | 歷史 |
| EXELExelixis, Inc. | COM | 1,079,681 | $1,967 萬 | 1.2% | +240,500+28.7% | 加碼 | 歷史 |
| AKUSAkouos, Inc. | COM | 1,515,074 | $1,901 萬 | 1.2% | 00.0% | 不變 | 歷史 |
| PODDInsulet Corp | Stock | 68,500 | $1,880 萬 | 1.1% | +51,000+291.4% | 加碼 | 歷史 |
| VRTXVertex Pharmaceuticals Inc | Stock | 88,214 | $1,779 萬 | 1.1% | +42,514+93.0% | 加碼 | 歷史 |
| RGNXREGENXBIO Inc. | COM | 427,740 | $1,662 萬 | 1.0% | +66,005+18.2% | 加碼 | 歷史 |
| NCNANuCana plc | SPONSORED ADR | 5,599,999 | $1,551 萬 | 0.9% | 00.0% | 不變 | 歷史 |
| AGENAgenus Inc | COM NEW | 2,769,900 | $1,521 萬 | 0.9% | −708,301−20.4% | 減碼 | 歷史 |
| DXCMDexcom Inc | COM | 33,713 | $1,440 萬 | 0.9% | +6,713+24.9% | 加碼 | 歷史 |
| OBSVObsEva SA | COM | 4,749,623 | $1,439 萬 | 0.9% | 00.0% | 不變 | 歷史 |
| ITCIIntra-Cellular Therapies, Inc. | COM | 313,159 | $1,278 萬 | 0.8% | −341,842−52.2% | 減碼 | 歷史 |
| MRTXMirati Therapeutics, Inc. | COM | 78,538 | $1,269 萬 | 0.8% | −59,492−43.1% | 減碼 | 歷史 |
| AGIOAgios Pharmaceuticals, Inc. | COM | 219,033 | $1,207 萬 | 0.7% | +219,033 | 新進 | 歷史 |
| RETAReata Pharmaceuticals Inc | CL A | 79,601 | $1,127 萬 | 0.7% | −158,919−66.6% | 減碼 | 歷史 |
| QUREuniQure N.V. | SHS | 324,303 | $998.9 萬 | 0.6% | −102,819−24.1% | 減碼 | 歷史 |
| AMGNAmgen Inc | Stock | 40,500 | $987.2 萬 | 0.6% | +1,632+4.2% | 加碼 | 歷史 |
| CYTKCytokinetics Inc | COM NEW | 481,323 | $952.5 萬 | 0.6% | +91,603+23.5% | 加碼 | 歷史 |
| KURAKura Oncology, Inc. | COM | 444,372 | $926.5 萬 | 0.6% | +361,208+434.3% | 加碼 | 歷史 |
| Nucana Biomed LtdGB00BYWYV | Ordinary Shares | 2,400,000 | $664.8 萬 | 0.4% | 00.0% | 不變 | – |
| MGNXMacrogenics Inc | COM | 234,504 | $629.9 萬 | 0.4% | +161,303+220.4% | 加碼 | 歷史 |
| ChemoCentryx, Inc.16383L106 | COM | 465,637 | $623.5 萬 | 0.4% | +285,638+158.7% | 加碼 | – |
| MRNSMarinus Pharmaceuticals, Inc. | COM NEW | 346,160 | $621.0 萬 | 0.4% | −24,191−6.5% | 減碼 | 歷史 |
| CHRSCoherus Oncology, Inc. | COM | 434,555 | $601.0 萬 | 0.4% | 00.0% | 不變 | 歷史 |
| CYTCyteir Therapeutics, Inc. | COM | 265,000 | $567.1 萬 | 0.3% | +265,000 | 新進 | 歷史 |
| IMTXImmatics N.V. | SHS | 443,370 | $514.8 萬 | 0.3% | +58,271+15.1% | 加碼 | 歷史 |
| AMRNAmarin Corp PLC | SPONS ADR NEW | 1,170,584 | $512.7 萬 | 0.3% | 00.0% | 不變 | 歷史 |
| TCRRTCR2 Therapeutics Inc. | COM | 296,282 | $486.2 萬 | 0.3% | −40,400−12.0% | 減碼 | 歷史 |
| CLDXCelldex Therapeutics, Inc. | COM NEW | 134,724 | $450.5 萬 | 0.3% | +134,724 | 新進 | 歷史 |
| MIRMMirum Pharmaceuticals, Inc. | COM | 259,465 | $448.6 萬 | 0.3% | −216,936−45.5% | 減碼 | 歷史 |
| JNCEJounce Therapeutics, Inc. | COM | 624,756 | $424.8 萬 | 0.3% | +112,934+22.1% | 加碼 | 歷史 |
| FATEFate Therapeutics Inc | COM | 46,386 | $402.6 萬 | 0.2% | −8,409−15.3% | 減碼 | 歷史 |
| ALGSAligos Therapeutics, Inc. | COM | 164,051 | $334.4 萬 | 0.2% | −21,481−11.6% | 減碼 | 歷史 |
| OTICOtonomy, Inc. | COM | 1,251,256 | $279.0 萬 | 0.2% | 00.0% | 不變 | 歷史 |
| REPLReplimune Group, Inc. | COM | 71,661 | $275.3 萬 | 0.2% | −70,548−49.6% | 減碼 | 歷史 |
| BCRXBiocryst Pharmaceuticals Inc | COM | 158,609 | $250.8 萬 | 0.2% | −220,165−58.1% | 減碼 | 歷史 |
| SYBXSynlogic, Inc. | COM | 574,972 | $223.7 萬 | 0.1% | 00.0% | 不變 | 歷史 |
| SVRASavara Inc | COM | 1,278,424 | $217.3 萬 | 0.1% | −459,026−26.4% | 減碼 | 歷史 |
| PDSBPDS Biotechnology Corp | COM | 142,635 | $179.0 萬 | 0.1% | 00.0% | 不變 | 歷史 |
| CTICCti Biopharma Corp | COM | 171,619 | $42.9 萬 | <0.1% | +171,619 | 新進 | 歷史 |
| SRRASierra Oncology, Inc. | COM NEW | 2,500 | $4.90 萬 | <0.1% | +2,500 | 新進 | 歷史 |
選擇權（6 檔）
同一份申報裡的賣權（put）與買權（call）。金額是標的股票的市值，也就是 13F 申報的數字。
| 證券 | 類別 | 賣權 | 買權 |
|---|---|---|---|
| iShares Tr464287956 | PUT | $5,319 萬 | – |
| ARK ETF Tr00214Q952 | PUT | $2,313 萬 | – |
| Fibrogen Inc31572Q958 | PUT | $532.6 萬 | – |
| Chemocentryx Inc16383L906 | CALL | – | $287.9 萬 |
| Acadia Pharmaceuticals Inc004225908 | CALL | – | $243.9 萬 |
| TCR2 Therapeutics Inc87808K956 | PUT | $229.2 萬 | – |
2021 年第 1 季之後清倉（10 檔）
2021 年第 1 季季末還持有、這份申報已經沒有的部位。
| 證券 | 類別 | 2021 年第 1 季股數 | 2021 年第 1 季市值 | 2021 年第 1 季佔組合 % | 紀錄 |
|---|---|---|---|---|---|
| JAZZJazz Pharmaceuticals plc | SHS USD | 255,928 | $4,207 萬 | 2.7% | 歷史 |
| LLYEli Lilly & Co | Stock | 180,501 | $3,372 萬 | 2.1% | 歷史 |
| MRUSMerus N.V. | COM | 1,311,039 | $2,739 萬 | 1.7% | 歷史 |
| HZNPHorizon Therapeutics Public Ltd Co | SHS | 133,997 | $1,233 萬 | 0.8% | 歷史 |
| LONALeonaBio, Inc. | COM | 509,168 | $936.9 萬 | 0.6% | 歷史 |
| SNDXSyndax Pharmaceuticals Inc | COM | 298,644 | $667.8 萬 | 0.4% | 歷史 |
| ARNAArena Pharmaceuticals Inc | COM NEW | 91,448 | $634.6 萬 | 0.4% | 歷史 |
| APTOAptose Biosciences Inc. | COM NEW | 696,928 | $416.4 萬 | 0.3% | 歷史 |
| PBYIPuma Biotechnology, Inc. | COM | 344,917 | $335.3 萬 | 0.2% | 歷史 |
| CALACalithera Biosciences, Inc. | COM | 757,533 | $183.3 萬 | 0.1% | 歷史 |